Prostatic Neoplasms D011471

Related MeSH Hierarchy (4)

Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Urogenital Neoplasms » Genital Neoplasms, Male » Prostatic Neoplasms

Diseases [C] » Male Urogenital Diseases [C12] » Genital Diseases, Male » Genital Neoplasms, Male » Prostatic Neoplasms

Diseases [C] » Male Urogenital Diseases [C12] » Genital Diseases, Male » Prostatic Diseases » Prostatic Neoplasms

Diseases [C] » Male Urogenital Diseases [C12] » Urogenital Neoplasms » Genital Neoplasms, Male » Prostatic Neoplasms

Description

Tumors or cancer of the PROSTATE.   MeSH

Subtype Terms (1)

Prostatic Neoplasms, Castration-Resistant
31 drugs (21 approved, 10 experimental)


Phase 3 Indicated Drugs (133)

Phase 2 Indicated Drugs (485)

103-palladium

111in-j591

131i-psma-1095

13c-pyruvate

177lu-psma-r2

18f-alf-nota-neurotensin

18f-naf

2-hydroxyflutamide

68ga-nota-ae105

68ga−psma−hbed−cc

68ga-rm2

89zr df-iab2m

89zr-df-iab2m

89zr dfo-mstp2109a

89zr-j591

a166

abemaciclib (verzenio)

abituzumab

abt-751

acai polyphenolics

acetic acid (vosol)

acetogenins

aciclovir (zovirax)

ad5-ycd/muttksr39rep-adp

adavosertib

adenoviral vector expressing hsv-tk

adenovirus/psa vaccine

ad-reic/dkk-3

adxs31-142

afatinib (gilotrif)

afuresertib

aldesleukin (proleukin)

alisertib

allogeneic adipose derived mesenchymal stem cell

allogeneic central memory t cells

allogeneic tumor cell vaccine

allostim

alprostadil (prostin)

alt-803

alvocidib

amg-208

amifostine (ethyol)

aminoglutethimide (cytadren)

amonafide

anastrazole

antineoplaston a10

anti-ox40

anti-psma designer t cells

apatorsen

apc-100

apc8015f

apitolisib

ard6562

arginine

arsenic trioxide (trisenox)

asp9521

autologous dendritic cells

autologous dendritic cells expressing tn-muc1

autologous dendritic cells loaded with autologous tumor lysate

autologous immune cells

avelumab (bavencio)

axitinib (inlyta)

azacitidine (vidaza)

azd-4547

azd4635

azd5312

azd-5672

azd6738

bafetinib

bavituximab

bay86-7548

berzosertib

betamethasone (celestone)

bi-2536

binimetinib (mektovi)

bintrafusp alfa

black tea

bortezomib (velcade)

br55

broxuridine

bryostatin

buparlisib

c11-sodium acetate

calcidiol

capecitabine (xeloda)

capromab pendetide (Prostascint)

capsaicin (qutenza)

carfilzomib (kyprolis)

carlumab

carmustine (bicnu)

carotenoids

carotuximab

ccs1477

cdca1

cediranib

cellulose

cemiplimab (libtayo)

cep-11981

cetuximab (erbitux)

cfg920

cfi-400945

cg7870

cgc-11047

chadox1-mva 5t4

chir-258

chitosan

cholesterol

cilengitide

cimetidine (tagamet)

cinacalcet (sensipar)

cixutumumab

clomifene (clomid)

colchicine (colbenemid)

conjugated equine estrogens

copanlisib (aliqopa)

cort125281

cpi-1205

crizotinib (xalkori)

ct-2584

cv301

cv787

cv9103

cv9104

cyanocobalamin (berocca)

cyclophosphamide (cytoxan)

cytarabine (cytosar-u)

dabrafenib (tafinlar)

dactolisib

danusertib

d-arabino-2-desoxyhexose

daratumumab (darzalex)

dc1 vaccine

dcfbc

dc/lncap

decaffeinated black tea

decitabine (dacogen)

defactinib

dendritic cells (dcs) loaded with hormone-refractory prostate cancer

dendritic cells dcvac/pca

dendritic cells loaded with prostate cancer

diclofenac (voltaren)

digoxin (lanoxin)

diindolylmethane

dipropyltryptamine

dkn-01

dolastatin

dovitinib

doxercalciferol (hectorol)

dupilumab (dupixent)

durvalumab (imfinzi)

efavirenz (sustiva)

eflornithine (ornidyl)

eft508

enzastaurin

epacadostat

ephb4-hsa fusion protein

epi-506

epirubicin (ellence)

epothilone

erdafitinib (Balversa)

eribulin (halaven)

erlotinib (tarceva)

esk981

estetrol

estrogen

etaracizumab (abegrin)

etodolac (lodine)

exatecan mesylate

exemestane (aromasin)

fermented wheat germ extract

fexapotide

figitumumab

fish oil (Omegavan)

flaxseed

fludeoxyglucose f-18

fluvastatin (lescol)

folic acid

fowlpox-gm-csf

fowlpox-prostate specific antigen vaccine

fowlpox virus vaccine

fpv-brachyury

fulvestrant (faslodex)

ga 68 dota-neobomb1

gadolinium

gadoxetate disodium (eovist)

gallium-68-dotatate (netspot)

gallium maltolate

galunisertib

ganetespib

ge-148

gefitinib (iressa)

gene-modified tumor cell vaccine therapy

germanium

gosspyl acetate

gpi 1485

grape extract

grape seed extract

grape skin extract

gs-5829

gsk-2636771

gti-2040

gtx-758

gvax pancreatic cancer vaccine

gx301

he3235

her2bi-armed activated t cells

hsvtk retrovirally-transduced donor t lymphocytes

htert mrna transduced dendritic cells

human fecal microbiota

humax-il8

hx4

hydrocortisone (solu-cortef)

hydroxychloroquine (plaquenil)

hyperacute-prostate cancer vaccine

ibrutinib (imbruvica)

icosapent ethyl (vascepa)

il-7

imatinib (gleevec)

immune globulin (human)

immuvac

inactivated influenza vaccine

incomplete freund's adjuvant

indomethacin (indocin)

indoximod

interferon alpha-2b (Intron-A)

interferon gamma-1b (actimmune)

interleukin-12

intetumumab

irofulven

isis 183750

isosorbide (isordil)

isotretinoin (accutane)

ispinesib

it-101

itraconazole (sporanox)

ixabepilone (ixempra)

jnj-809

kanglaite

kos862

kpt-8602

kx2-391

l-377202

lae001

lapatinib (tykerb)

larotrectinib (vitrakvi)

lestaurtinib

leuvectin

levobupivacaine (chirocaine)

l-glutamine

licorice root extract

lidocaine (xylocaine)

linsitinib

litgenprostucel-l

lovastatin (mevacor)

lu177 monoclonal antibody j591

ly2181308

ly-2452473

ly-3023414

masoprocol (actinex)

mcs110

memantine (namenda)

me tarp vaccine

metformin (glucophage)

methylphenidate (ritalin)

metilcelulosa

metronidazole (flagyl)

mgi-114

mifepristone (mifeprex)

milk protein

mipsagargin

mk-1775

mln-2704

mrna from psa, pap, survivin and htert transfected dendritic cell

msb0011359c

msk-2206

muscadine

Muscadine Grape Extract

mva.5t4

mva-bn-brachyury

mva-muc1-il2

myeloid dendritic cells

n-(4-hydroxyphenyl)all-trans retinamide

naltrexone (revia)

naproxen (naprosyn)

navitoclax

nebentan

nedisertib

nexrutine

niclosamide (nicloside)

nintedanib (ofev)

noni extract

nrx194204

obi-3424

oblimersen sodium

octreotide (sandostatin)

odm-204

odm-208

odm-209

olaratumab (lartruvo)

oleclumab

onalespib

onapristone

oncoxin-viusid

onvansertib

ony-p1

opaganib

opb-111001

orca-010

osi-461

osimertinib (tagrisso)

osteodex

oxaliplatin (eloxatin)

ozarelix

palbociclib (ibrance)

pamiparib

panitumumab (vectibix)

panobinostat (farydak)

pantoprazole (protonix)

papaverine

paratyphoid a and b vaccine

paricalcitol (zemplar)

patupilone

pazopanib (votrient)

pd-1 knockout t cells

pemetrexed (alimta)

pep223

perflutren protein-type a microspheres (Optison)

perifosine

perillyl alcohol

peripheral blood hematopoietic cell

pertuzumab (perjeta)

pexidartinib (Turallo)

pf-04518600

phenelzine (nardil)

phenoxodiol

phentolamine mesylate (regitine)

phenylacetic acid (ucephan)

phenylacetylgluatmine

pi-88

picoplatin

pidilizumab

pimonidazole

pioglitazone (actos)

plasmacytoid dendritic cells

plitidepsium

polyethylene glycol 3350 (colyte)

polyunsaturated fatty acids

pomalidomide (pomalyst)

pomegranate

pomegranate extract

pomegranate juice

pomx

pracinostat

prednisolone (hydeltra)

prevastein hc

prexasertib

propranolol (inderal)

proscavax

prostate specific membrane antigen

prostatic acid phosphatase-sargramostim fusion protein

prostvac-v/tricom

proxalutamide

psa:154-163 peptide vaccine

psa prostate cancer vaccine

psa rna-pulsed dendritic cell vaccine

psma car-t cell

ptvg-ar

ptvg-hp

ptvg-hp plasmid dna vaccine

pvaxrcpsav53l

pyridoxine

qs-21

quinacrine

raloxifene (evista)

ramucirumab (cyramza)

rebimastat

recombinant human choriogonadotropin alfa (Ovidrel)

regn5678

rf-psa

ribociclib (kisqali)

ridaforolimus

rilotumumab

rimabotulinumtoxinB (Myobloc)

rintatolimod

ritonavir (Norvir)

ro4929097

rocuronium (zemuron)

romidepsin (istodax)

romiplostim (nplate)

rubitecan

ruxolitinib (jakafi)

rv001v

rv-b7.1

rv-psa

sabarubicin

sacituzumab govitecan

sagopilone

samarium

sapanisertib

saracatinib

savolitinib

saw palmetto

sd-101

selinexor (Xpovio)

sepantronium bromide

seviteronel

sgn-15

shr2554

shr3162

silibrin

siltuximab (sylvant)

simvastatin (zocor)

sm153 lexidronam pentasodium

sm88

sodium acetate

sodium phenylbutyrate (buphenyl)

sonolisib

sorafenib (nexavar)

soy isoflavones

squalamine

sr31747

staphylococcus aureus vaccine

sulfasalazine (azulfidine)

sulforaphane

sulindac (clinoril)

tak-448

talabostat

talazoparib (talzenna)

tandutinib

tanespimycin

tarenflurbil

taselisib

tasidotin

taxoprexin

tecemotide

temozolomide (temodar)

temsirolimus (torisel)

tesetaxel

testosterone (delatestryl)

tiomolibdate ion

tisotumab vedotin

tivantinib

tivozanib (Fotivda)

topotecan (hycamtin)

topsalysin

torcoxia

tpi-287

trabectedin (yondelis)

trametinib (mekinist)

trastuzumab (herceptin)

trastuzumab emtansine (kadcyla)

trc253

trebananib

tremelimumab

tresulfan

tretinoin (Retin-A)

triapine

trilostane (modrastane)

trovafloxacin (trovan)

trovax

trx518

typhoid vaccine

utomilumab

vaccinia-b7.1 vaccine

vaccinia prostate-specific antigen vaccine

vaccinia-tricom vaccine

vadimezan

val201

valproic acid (depakene)

vandetanib (caprelsa)

vatalanib

vdc2008

veliparib

venetoclax (venclexta)

veru-111

vinflunine

vinorelbine (navelbine)

vismodegib (erivedge)

vitamin c

vorinostat (zolinza)

walnut

wst11

zarnestra

zoptarelin doxorubicin

10 valent pneumococcal conjugate vaccine

Phase 1 Indicated Drugs (205)


Organization Involved with Phase 3 Indications (197)

Organization Involved with Phase 2 Indications (318)

Abgenix

Adamis Pharmaceuticals Corporation

Advanced Accelerator Applications

Advaxis, Inc.

Aga Khan University

Alberta Cancer Foundation

All-Russia Centre for Urgent Care and Radiation Medicine

Antisoma Research

Arizona Oncology Services

Arno Therapeutics

Ascenta Therapeutics

Assistance Publique - Hôpitaux de Paris

Association of Urogenital Oncology (AUO)

Astex Pharmaceuticals, Inc.

Athenex, Inc.

Attenuon

Augusta University

Australian and New Zealand Urogenital and Prostate Cancer Trials Group

Azienda Ospedaliera San Camillo Forlanini

Bajcsy-Zsilinszky Hospital

Baylor University

BeiGene

Besins Healthcare

BIND Therapeutics

BioXcel Therapeutics Inc

Boehringer Ingelheim

Boston University

Bostwick Laboratories

Brown University

Burzynski Research Institute

BZL Biologics

Cadila Healthcare

Camurus AB

Cancer Immunotherapy Trials Network

Cancer Research Antwerp

Cancer Therapeutics Research Group

Cancer Trials Ireland

Cardiff Oncology

Carolina Research Professionals, LLC

Carolina Urologic Research Center

CASI Pharmaceuticals, Inc.

Catalysis SL

Cedars-Sinai Medical Center

CellCentric Ltd.

Cellular Biomedicine Group Ltd.

Centocor

Central European Society for Anticancer Drug Research (CESAR)

Central South University

Cephalon

Changhai Hospital

Chao Family Comprehensive Cancer Center

Charles University

Chatrapati Sahuji Mahraj Medical University

Choithram Hospital and Research Centre

Christian Medical College, Vellore, India

CHU Mont-Godinne

Churchill Pharmaceutical LLC

City Clinical Hospital # 57

City of Hope National Medical Center

Cleveland BioLabs

Comprehensive Cancer Centers of Nevada

Constellation Pharmaceuticals

Corcept Therapeutics

Cortice Biosciences, Inc.

CTI BioPharma

CureVac AG

Cytogen

CytRx

Daiichi Sankyo

Dalhousie University

DanTrials ApS, Copenhagen, Denmark

Desert Regional Comprehensive Cancer Center

DexTech Medical AB

Duramed Research

Effector Therapeutics

Eisai

Eli Lilly

ESSA Pharmaceuticals

Excel Diagnostics and Nuclear Oncology Center

Free University of Brussels

Frimley Park Hospital NHS Trust

Fundación Canaria de Investigación Sanitaria

Genentech

General Electric

Genmab

Genta

Genzyme

Georgetown University

German Cancer Research Center

Gilead Sciences

Government of Canada

Government of Russia

Government of Taiwan

Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)

Groupe D'Etude des Tumeurs Uro-Genitales

Guangdong Pharmaceutical University

Guangzhou University

Hamilton Health Sciences Corporation

Harbor Therapeutics

Health Ever Bio-Tech Co., Ltd.

Hebrew University

Hellenic Cooperative Oncology Group

Henry Ford Health System

Herbert Irving Comprehensive Cancer Center

Hoag Memorial Hospital Presbyterian

Hoosier Cancer Research Network

Hope Cancer Institute, Inc.

Hospital Moinhos de Vento

Icahn School of Medicine at Mount Sinai

Illinois CancerCare, P.C.

ImaginAb, Inc.

Immunomedics

Immunovative Therapies

Incyte

Infinity Pharmaceuticals, Inc.

Innocrin Pharmaceutical

Inova Health System

Inspyr Therapeutics, Inc.

Institut Bergonié

Institut Mutualiste Montsouris

Instituto do Cancer do Estado de São Paulo

Insys Therapeutics Inc

Ionis Pharmaceuticals, Inc.

Io Therapeutics

Istituto Nazionale per lo Studio e la Cura dei Tumori

Italian Trial in Medical Oncology

Iwate Medical University

Jahn Ferenc South Pest Hospital

James Graham Brown Cancer Center

Jiao Tong University

Jinan University

Kael-GemVax Co., Ltd.

Kaiser Permanente

Kantonsspital Graubünden

Karyopharm Therapeutics Inc

Kasturba Medical College

Kidwai Memorial Institute of Oncology, Bangalore

Klus Pharma Inc.

Korea University

Laboratoires Leurquin Mediolanum

Laekna Limited

Latin American Cooperative Oncology Group

Laval University

Leap Therapeutics, Inc.

Lidds AB

Louisiana State University

LTMMC & LTMGH

Maastricht University

Macquarie University

Mansoura University

Mayo Clinic

Medical University of South Carolina

Medical University of Vienna

MedImmune

MedSIR

MEI Pharma

Merck Serono

Merrion Pharmaceuticals, LLC

Methodist Cancer Center, Houston, Texas

Michigan State University

Modra Pharmaceuticals

Momotaro-Gene Inc.

Moorgreen Hospital, Southampton

Morton Plant Mease Health Care

Moscow Oncology Research Institute

Myrexis Inc.

Nanjing Medical University

NanOlogy, LLC

National Center for Complementary and Integrative Health (NCCIH)

National Health Service, United Kingdom

National University of Ireland

National University of Singapore

Nerviano Medical Sciences

NewLink Genetics Inc

New York University

Northwell Health

Nymox Corporation

OBI Pharma, Inc

Ohio State University

OHSU Knight Cancer Institute

OncBioMune, LLC

Oncology Specialists, S.C.

Oncology Venture

Oncotech

Optimal Health Research

Orca Therapeutics B.V.

Orion Corporation

Osaka City University

Osaka University

Otsuka

Oxford BioMedica

Palacky University

Panacela Labs LLC

Pantarhei Bioscience

Patel Hospital Pvt. Ltd.

Peachtree Hematology Oncology Consultants

Pennsylvania State University

Pepscan Therapeutics

Peterfy Sandor Street Hospital

PharmaMar

Phoenix Molecular Imaging

Piramal

Plexxikon

POM Wonderful LLC

Poniard Pharmaceuticals

Postgraduate Institute of Medical Education and Research

Progen Pharmaceuticals

Prostate Cancer Clinical Trials Consortium

Prostate Institute of America

Providence Health & Services

Radio Isotope Therapy of America

Rajiv Gandhi University of Health Sciences

Rampart Health, L.L.C.

RCC, Trivandrum

Regeneron

Research Institute of Oncology n.a. Professor N.N. Petrov under the Federal Agency for Healthcare and Social Development

RhoVac

Rockefeller University

Royal Marsden Hospital NHS Trust

RTOG Foundation

Russian Academy of Medical Sciences

Rutgers University

Saarland University

Safdarjang Hospital

SCRI Development Innovations

Seattle Genetics

Seoul National University

Seth Gordhandas Sunderdas Medical College

Shaheed Beheshti Medical University

Shanghai Bioray Laboratory Inc.

Singapore General Hospital

Sophiris Bio Corp

Spectrum Pharmaceuticals

St. Barnabas Medical Center, Livingston, NJ

St. Luke's-Roosevelt Hospital Center

St. Petersburg State Public Medical Institution

St. Vincent's Hospital-Manhattan

Sungkyunkwan University

Suzhou Kintor Pharmaceutical Inc,

Taiwan Cooperative Oncology Group

The Adelaide and Meath Hospital

The European Uro-Oncology Group

The Queen's Medical Center

Theradex

Theragnostics Ltd

Therion Biologics Corporation

The University of Texas Health Science Center, Houston

Thomayer's Hospital

Tiltan Pharma

Titan Pharmaceuticals

Tracon Pharmaceuticals Inc.

Transgene

Translational Oncology Research International

Tulane University

Tyme, Inc

Ultimovacs AS

Universidad Autonoma de Madrid

Universidad Carlos III Madrid

Université catholique de Louvain

University of Alabama, Birmingham

University of Alberta

University of Antwerp

University of Athens

University of Birmingham

University of Bordeaux

University of Caen-Normandie

University of Calgary

University of California, Irvine

University of California, San Diego

University of Cambridge

University of Central Florida

University of Chicago

University of Colorado, Denver

University of Florida

University of Hamburg

University of Havana

University of Hawaii

University of Heidelberg

University of Ioannina

University of Kansas

University of Kentucky

University of Maryland

University of Medicine and Dentistry of New Jersey

University of Miami

University of Minnesota

University of Naples Frederico II

University of Nebraska

University of New South Wales

University of Nice Sophia Antipolis

University of North Carolina at Chapel Hill

University of Nottingham

University of Oslo

University of Pilsen

University of Quebec

University of South Carolina

University of Southern California

University of Ulsan

University of Valencia

University of Wisconsin

Uppsala University

US Oncology

ValiRx

Veeda Clinical Research

Veru Inc.

Vical

Vicus Therapeutics

Vion Pharmaceuticals

Virginia Commonwealth University

Virginia Mason Medical Center

Virginia Oncology Associates

Vita-Salute University of Milano. Italy

Wayne State University

Whittingham Cancer Center

Winthrop University

Wroclaw Medical University

Xanthus Pharmaceuticals, Inc.

Yeshiva University

Zhejiang Kanglaite Pharmaceutical Co.Ltd

Organization Involved with Phase 1 Indications (96)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.